| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/06/1994 | EP0589982A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 04/06/1994 | EP0589943A1 Mycobacterium proteins and applications |
| 04/06/1994 | EP0589928A1 Cold tolerances in plants |
| 04/06/1994 | EP0589894A1 Insecticidally effective peptides |
| 04/06/1994 | EP0589875A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 04/06/1994 | EP0371026B1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/06/1994 | EP0229126B1 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors |
| 04/05/1994 | US5300632 Method for purifying an outer membrane protein of Haemophilus influenzae |
| 04/05/1994 | US5300631 Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same |
| 04/05/1994 | US5300564 Forming a glassy polymer in the presence of a reagent to trap the reagent; having a gas or liquid component in solution to diffuse through the pores; immobilized enzymes; detectors; pollution control; immunoassay |
| 04/05/1994 | US5300434 Determing collagen degradation in vivo |
| 04/05/1994 | US5300433 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 04/05/1994 | US5300425 Providing antibodies which are ivnerse images of diverse mimotpes |
| 04/05/1994 | US5300278 Binding antibodies |
| 03/31/1994 | WO1994007143A1 Diagnosis of autosomal muscular dystrophy |
| 03/31/1994 | WO1994006929A1 Small cell lung carcinoma specific antibody and antigen |
| 03/31/1994 | WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006826A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | WO1994006745A1 Method for making valproic acid derivatives |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006474A1 ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI) |
| 03/31/1994 | WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006469A1 Hiv fusion polypeptide |
| 03/31/1994 | WO1994006463A1 Immortalized cells and uses therefor |
| 03/31/1994 | WO1994006459A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | WO1994006456A1 Protection against liver damage by hgf |
| 03/31/1994 | WO1994006449A2 Morphogen-induced liver regeneration |
| 03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/31/1994 | WO1994006420A2 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | WO1994006399A1 Morphogen-induced periodontal tissue regeneration |
| 03/31/1994 | WO1994004691A3 Dimer and multimer forms of single chain polypeptides |
| 03/31/1994 | WO1994003605A3 Compositions and methods for detecting human herpesvirus 6 strain z29 |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | CA2145179A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144750A1 Tumor-specific antibodies and antigen |
| 03/31/1994 | CA2144651A1 Immortalized cells and uses therefor |
| 03/31/1994 | CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | CA2144515A1 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | CA2144435A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | CA2122816A1 Method for making valproic acid derivatives |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589487A1 Monoclonal antibodies for small organic molecules |
| 03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/30/1994 | CN1084407A Method for producing clostridium perfringens vaccines |
| 03/29/1994 | US5298605 Diabetes |
| 03/29/1994 | US5298599 Fusion protein |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298491 Analytical kit |
| 03/29/1994 | US5298420 Binds to peptide segment having thirteen amino acids |
| 03/29/1994 | US5298419 Diagnosis |
| 03/29/1994 | US5298409 Antibody-enhanced stereospecific hydrolyses |
| 03/29/1994 | US5298407 DNA encoding a protein active in lymphocyte-mediated cytotoxicity |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
| 03/29/1994 | US5298393 Monoclonal antibody for human acid-glutathione S-transferase and process for preparation thereof |
| 03/29/1994 | CA2106693A1 Immunoassay for isothiazolones |
| 03/29/1994 | CA1328147C Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy |
| 03/29/1994 | CA1328071C Vaccine against pasteurella |
| 03/23/1994 | EP0588750A2 Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0588036A2 Composition for isolating apamin receptors, apamin binding protein and uses thereof |
| 03/23/1994 | EP0587873A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 03/23/1994 | EP0587788A1 Methods and compositions of genetic stress response systems |
| 03/23/1994 | EP0587777A1 Cea-binding proteins and methods for their isolation and use |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587719A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO) |
| 03/23/1994 | EP0587676A1 A mouse immunoglobulin heavy-chain locus enhancer which crosshybridizes with the 3'-enhancer element of rat |
| 03/23/1994 | EP0587636A1 Fish vaccine for aeromonas salmonicida infection |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | CN1084216A Method of intracellular binding of target molecules |
| 03/22/1994 | US5296594 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 03/22/1994 | US5296354 Kit for the specific assay of angiotensin II |
| 03/22/1994 | US5296353 Evaluation and treatment of patients with progessive immunosuppression |
| 03/22/1994 | US5296352 Monoclonal antibodies directed against complexes formed by thrombin and hirudin |
| 03/22/1994 | US5296348 Selecting antibody specific for surface antigen on tumor cell |
| 03/17/1994 | WO1994006016A1 New tumor cell marker |
| 03/17/1994 | WO1994005811A1 CLONING AND EXPRESSION OF βAPP-C100 RECEPTOR |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005789A1 Glucagon receptors |
| 03/17/1994 | WO1994005781A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |